Success Metrics

Clinical Success Rate
100.0%

Based on 17 completed trials

Completion Rate
100%(17/17)
Active Trials
1(5%)
Results Posted
35%(6 trials)

Phase Distribution

Ph phase_1
8
36%
Ph phase_2
4
18%
Ph phase_4
2
9%
Ph phase_3
8
36%

Phase Distribution

8

Early Stage

4

Mid Stage

10

Late Stage

Phase Distribution22 total trials
Phase 1Safety & dosage
8(36.4%)
Phase 2Efficacy & side effects
4(18.2%)
Phase 3Large-scale testing
8(36.4%)
Phase 4Post-market surveillance
2(9.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

94.4%

17 of 18 finished

Non-Completion Rate

5.6%

1 ended early

Currently Active

1

trials recruiting

Total Trials

22

all time

Status Distribution
Active(1)
Completed(17)
Terminated(1)
Other(3)

Detailed Status

Completed17
unknown3
Recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
22
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 18 (36.4%)
Phase 24 (18.2%)
Phase 38 (36.4%)
Phase 42 (9.1%)

Trials by Status

unknown314%
recruiting15%
withdrawn15%
completed1777%

Recent Activity

Clinical Trials (22)

Showing 20 of 22 trialsScroll for more
NCT03013751Phase 3

A Extension Study of Udenafil in Adolescents

Completed
NCT05918211Phase 3

Fontan Udenafil Exercise Longitudinal Assessment Trial - 2

Recruiting
NCT03430583Phase 3

Evaluation of Fontan-associated Hepatic Stiffness and the Efficacy of Udenafil in Reducing Liver Stiffness

Completed
NCT02741115Phase 3

Fontan Udenafil Exercise Longitudinal Assessment Trial

Completed
NCT02201342Phase 1

Pharmacokinetic/Pharmacodynamic Study of Udenafil in Adolescents

Completed
NCT02304198Phase 2

Clinical Trial to Evaluate the Long-term Safety of Udenafil in Patient With PAH

Completed
NCT01553721Phase 2

Efficacy and Safety Study of Udenafil in Patient With Pulmonary Arterial Hypertension(PAH)

Completed
NCT01967251Phase 2

Efficacy, Safety and Dose-response of Udenafil in Patients With Benign Prostatic Hyperplasia and Erectile Dysfunction

Withdrawn
NCT01037218Phase 3

Treatment of Erectile Dysfunction II

Completed
NCT01421940Phase 4

The Efficacy of Penile Rehabilitation Using Udenafil After Total Mesorectal Excision of Rectal Cancer

Completed
NCT01769482Phase 4

Understanding of Chest Pain in Microvascular Disease Proved by Cardiac Magnetic Resonance Image

Unknown
NCT01929213Phase 1

Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Udenafil and Bosentan After Oral Administration

Unknown
NCT01967264Phase 1

Safety and Pharmacokinetic Profile of Udenafil in Healthy Mexican Adults

Completed
NCT01928563Phase 1

Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Udenafil and Dapoxetine

Unknown
NCT00956306Phase 1

A Pharmacokinetic Study of Udenafil in Adult Subjects With or Without Impaired Hepatic Function

Completed
NCT00607282Phase 2

Efficacy of Udenafil After Radical Resection for Sigmoid Colon and Rectal Cancer

Completed
NCT01305083Phase 3

Efficacy and Safety Study of Udenafil Tablets in Erectile Dysfunction.

Completed
NCT01037244Phase 3

Treatment of Erectile Dysfunction I

Completed
NCT01230541Phase 1

Effect of Udenafil on Spermatogenesis

Completed
NCT01364181Phase 3

The Impact of Udenafil on Exercise Capacity in Severe Chronic Obstructive Pulmonary Disease (COPD) Patients

Completed

Drug Details

Intervention Type
DRUG
Total Trials
22